Nuzenio

Free Survival

Free Survival news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 14 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Avoiding these 3 risk factors might buy you 13 more dementia-free years - The Washington PostThe Washington Post · Fri, 07 Aug 2026 17:00:01 GMT Trastuzumab Rezetecan Improves Progression-Free Survival in HER2-Positive Metastatic Breast Cancer - The ASCO PostThe ASCO Post · Fri, 07 Aug 2026 14:42:22 GMT Three Factors Tied to 13 Additional Dementia-Free Years - MedPage TodayMedPage Today · Thu, 06 Aug 2026 16:57:50 GMT HRR-Altered Metastatic Prostate Cancer Talazoparib Plus Enzalutamide Improves Progression-Free Survival - The ASCO PostThe ASCO Post · Thu, 06 Aug 2026 14:00:43 GMT Long-Term OMNIVORE Data Show Durable Treatment-Free Survival After Nivolumab in Advanced RCC - OncLiveOncLive · Thu, 06 Aug 2026 12:18:02 GMT Midlife Vascular Health Adds Nearly 13 Dementia-Free Years - Neuroscience NewsNeuroscience News · Wed, 05 Aug 2026 20:53:36 GMT Enfortumab Vedotin-Induced Skin Reactions Linked to Better Survival - EMJEMJ · Wed, 05 Aug 2026 13:08:08 GMT AdAlta reports two year cancer free survival after single dose of experimental mesothelioma therapy - biotechdispatch.com.aubiotechdispatch.com.au · Wed, 05 Aug 2026 09:32:35 GMT

Timeline

Fri, 07 Aug 2026 17:00:01 GMTAvoiding these 3 risk factors might buy you 13 more dementia-free years - The Washington Post

Fri, 07 Aug 2026 14:42:22 GMTTrastuzumab Rezetecan Improves Progression-Free Survival in HER2-Positive Metastatic Breast Cancer - The ASCO Post

Thu, 06 Aug 2026 16:57:50 GMTThree Factors Tied to 13 Additional Dementia-Free Years - MedPage Today

Thu, 06 Aug 2026 14:00:43 GMTHRR-Altered Metastatic Prostate Cancer Talazoparib Plus Enzalutamide Improves Progression-Free Survival - The ASCO Post

Thu, 06 Aug 2026 12:18:02 GMTLong-Term OMNIVORE Data Show Durable Treatment-Free Survival After Nivolumab in Advanced RCC - OncLive

Wed, 05 Aug 2026 20:53:36 GMTMidlife Vascular Health Adds Nearly 13 Dementia-Free Years - Neuroscience News

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

The ASCO Post4 live mentions The Washington Post3 live mentions Progression3 live mentions EurekAlert3 live mentions Avoiding2 live mentions Trastuzumab Rezetecan Improves2 live mentions Positive Metastatic Breast2 live mentions Cancer2 live mentions Cancer The ASCO2 live mentions Post The ASCO2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Free Survival.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.